To understand why reviews and complaints are separated, it's essential to examine both sides in detail
Clinical studies Despite their thriving role in the treatment of obesity 214 , only seven studies investigated the effects of GLP-1RAs in eating disorders (Table 6), including some on their psychopathology in comorbid obesity 215,216,217 and others specifically in binge-eating disorder (BED) 217,218,219,220 , and we could not find any ongoing trial in this area
Report to the authorities
Compounded tirzepatide costs scale directly with dose, making lower maintenance doses significantly more affordable
One of the gallbladder-related risks associated with GLP-1 weight-loss medications, gallstone formation, is no longer relevant once the gallbladder has been removed
Bottom line: a symptom becomes a pattern the moment it is logged next to dose day, food, and water instead of standing alone